Patient Characteristics
| Characteristic | Value |
| Age (y) | |
| Median | 66 |
| Range | 37–87 |
| Sex (n) | |
| Male | 26 (53.06) |
| Female | 23 (46.94) |
| Race (n) | |
| White | 45 (91.84) |
| Other* | 4 (8.16) |
| Karnofsky performance status (n) | |
| <80 | 8 (16.33) |
| 80 | 19 (38.78) |
| >80 | 22 (44.90) |
| Weight loss (n) | |
| <5% | 8 (16.33) |
| ≥5% | 41 (83.67) |
| Smoking history (n) | |
| Current smoker | 11 (22.45) |
| Quit smoking | 35 (71.43) |
| Never smoked | 3 (6.12) |
| Histology (n) | |
| Adenocarcinoma | 19 (38.78) |
| Squamous | 19 (38.78) |
| NSCLC, not otherwise specified | 11 (22.45) |
| Clinical stage (n) | |
| IIIA | 17 (34.69) |
| IIIB | 32 (65.31) |
| Induction chemotherapy (n) | |
| Yes | 10 (20.41) |
| No | 39 (79.59) |
| Concurrent chemotherapy (n) | |
| Yes | 47 (95.92) |
| No | 2 (4.08) |
| Adjuvant chemotherapy (n) | |
| Yes | 17 (34.69) |
| No | 32 (65.31) |
| Radiation technique (n) | |
| Intensity-modulated radiation therapy | 42 (85.71) |
| Proton-beam therapy | 7 (14.29) |
| Radiation dose (n) | |
| Median | 66 |
| Range | 63–74 |
↵* Other includes African Americans and Asians.
Data in parentheses are percentages.